COVID-19 Community Open Access (recommended)
Institutional Collection
The COVID-19 Community houses resources on the Coronavirus (Covid-19), including clinical reports, management guidelines, and commentary authored by Feinberg School of Medicine faculty, staff, and students.
Descriptions
- Keyword
- coronavirus
covid
COVID-19
- Publisher
-
DigitalHub. Galter Health Sciences Library & Learning Center
- Total Items
-
74
- Size
-
66.1 MB
Items in this Collection
COVID-19 Community
Add to collection
You do not have access to any existing collections. You may create a new collection.
- Title:
- A clade of SARS-CoV-2 viruses associated with lower viral loads in patient upper airways
- Description:
- Lorenzo-Redondo R, Nam HH, Roberts SC, Simons LM, Jennings LJ, Qi C, Achenbach CJ, Hauser AR, Ison MG, Hultquist JF, Ozer EA. A Clade of SARS-CoV-2 viruses associated with lower viral loads in patient upper airways. Ebiomedicine. 2020;62:10.
- Abstract:
- Background: The rapid spread of SARS-CoV-2, the causative agent of Coronavirus disease 2019 (COVID-19), has been accompanied by the emergence of distinct viral clades, though their clinical significance remains unclear. Here, we aimed to investigate the phylogenetic characteristics of SARS-CoV-2 infections in Chicago, Illinois, and assess their relationship to clinical parameters. Methods: We performed whole-genome sequencing of SARS-CoV-2 isolates collected from COVID-19 patients in Chicago in mid-March, 2020. Using these and other publicly available sequences, we performed phylogenetic, phylogeographic, and phylodynamic analyses. Patient data was assessed for correlations between demographic or clinical characteristics and virologic features. Findings: The 88 SARS-CoV-2 genome sequences in our study separated into three distinct phylogenetic clades. Clades 1 and 3 were most closely related to viral sequences from New York and Washington state, respectively, with relatively broad distributions across the US. Clade 2 was primarily found in the Chicago area with limited distribution elsewhere. At the time of diagnosis, patients infected with Clade 1 viruses had significantly higher average viral loads in their upper airways relative to patients infected with Clade 2 viruses, independent of disease severity. Interpretation: These results show that multiple variants of SARS-CoV-2 were circulating in the Chicago area in mid-March 2020 that differed in their relative viral loads in patient upper airways. These data suggest that differences in virus genotype can impact viral load and may influence viral spread. (C) 2020 The Authors. Published by Elsevier B.V.
- Keyword:
- SARS-CoV-2, COVID-19, Phylogenetics, Viral load, Viral genotype, Whole genome sequencing
- Creator:
- Lorenzo-Redondo, Ramon, Nam, Hannah H., Roberts, Scott C., Simons, Lacy M., Jennings, Lawrence J., Qi, Chao, Achenbach, Chad J., Hauser, Alan R., Ison, Michael G., Hultquist, Judd F., Ozer, Egon A.
- Publisher:
- ELSEVIER
- Date Created:
- 2020-12
- Rights:
- http://creativecommons.org/licenses/by-nc-nd/3.0/us/
- Resource Type:
- Article
- Original Identifier:
- (PMID) 33186810
- Title:
- A Framework for Maintaining a Fully Operational Autopsy Service at a Large Academic Teaching Institution During a Global Pandemic
- Description:
- Fu L, Zak T, Shanes E. A Framework for Maintaining a Fully Operational Autopsy Service at a Large Academic Teaching Institution During a Global Pandemic. Academic Pathology. 2021;8:8.
- Abstract:
- The COVID-19 pandemic created new challenges in health care, and pathology departments have led with innovations in testing and education. While the medical community and public showed great interest in gross and histologic findings in COVID-affected patients, paradoxically many autopsy services nationwide closed due to uncertainties surrounding the proximity to infected patient tissue, shortages in personal protective equipment, and pressures to discontinue perceived nonessential hospital operations. These disruptions furthermore negatively impacted pathology trainee education. The autopsy division at Northwestern Memorial Hospital, with the belief that a fully functioning autopsy service is especially crucial at this time, adopted a framework for continuing at full capacity for both clinical care and education. New operations were modeled on national protocols by the Centers for Disease Control and Prevention and the College of American Pathologists, and the service continually adjusted policies to reflect rapidly changing guidelines and feedback from trainees and staff. Between January and December 2020, we performed 182 adult autopsies including 45 COVID-19 autopsies. Twelve residents, 4 staff, and 5 attendings rotated through the service. In exit interviews, participants expressed: (1) improved comfort managing both COVID-related and general autopsies; (2) sense of personal safety on service (despite the increased risk of exposure); (3) belief that both COVID-related and general autopsies contributed to their personal education and to the medical community. There have been zero known autopsy-related COVID-19 infections to date. We hope that our innovative autopsy service restructuring can serve as a framework for other academic programs during the current and in future pandemics.
- Keyword:
- autopsy, COVID-19, academic, resident, pandemic, education
- Creator:
- Fu, Lucy, Shanes, Elisheva Douglas, Zak, Taylor J
- Publisher:
- SAGE PUBLICATIONS INC
- Date Created:
- 2021-04-07
- Rights:
- http://creativecommons.org/licenses/by-nc-nd/3.0/us/
- Resource Type:
- Anecdotes
- Original Identifier:
- (PMID) 33884293
- Title:
- A method for detection of SARS-CoV-2 RNA in healthy human stool: a validation study
- Description:
- Coryell MP, Iakiviak M, Pereira N, Murugkar PP, Rippe J, Williams DB, Heald-Sargent T, Sanchez-Pinto LN, Chavez J, Hastie JL, Sava RL, Lien CZ, Wang TT, Muller WJ, Fischbach MA, Carlson PE. A method for detection of SARS-CoV-2 RNA in healthy human stool: a validation study. Lancet Microbe. 2021;2(6):E259-E266.
- Abstract:
- Background Faecal shedding of SARS-CoV-2 has raised concerns about transmission through faecal microbiota transplantation procedures. Validation parameters of authorised tests for SARS-CoV-2 RNA detection in respiratory samples are described in product labelling, whereas the published methods for SARS-CoV-2 detection from faecal samples have not permitted a robust description of the assay parameters. We aimed to develop and validate a test specifically for detection of SARS-CoV-2 in human stool. Methods In this validation study, we evaluated performance characteristics of a reverse transcriptase real-time PCR (RT-rtPCR) test for detection of SARS-CoV-2 in human stool specimens by spiking stool with inactivated SARS-CoV-2 material. A modified version of the US Centers for Disease Control and Prevention RT-rtPCR SARS-CoV-2 test was used for detection of viral RNA. Analytical sensitivity was evaluated in freshly spiked stool by testing two-fold dilutions in replicates of 20. Masked samples were tested by a second laboratory to evaluate interlaboratory reproducibility. Short-term (7-day) stability of viral RNA in stool samples was assessed with four different stool storage buffers (phosphate-buffered saline, Cary-Blair medium, Stool Transport and Recovery [STAR] buffer, and DNA/RNA Shield) kept at -80 degrees C, 4 degrees C, and ambient temperature (approximately 21 degrees C). We also tested clinical stool and anal swab specimens from patients who were SARS-CoV-2 positive by nasopharyngeal testing. Findings The lower limit of detection of the assay was found to be 3000 viral RNA copies per g of original stool sample, with 100% detection across 20 replicates assessed at this concentration. Analytical sensitivity was diminished by approximately two times after a single freeze-thaw cycle at -80 degrees C. At 100 times the limit of detection, spiked samples were generally stable in all four stool storage buffers tested for up to 7 days, with maximum changes in mean threshold cycle values observed at -80 degrees C storage in Cary-Blair medium (from 29.4 [SD 0.27] at baseline to 30.8 [0.17] at day 7; p<0.0001), at 4 degrees C storage in DNA/RNA Shield (from 28.5 [0.15] to 29.8 [0.09]; p=0.0019), and at ambient temperature in STAR buffer (from 30.4 [0.24] to 32.4 [0.62]; p=0.0083). 30 contrived SARS-CoV-2 samples were tested by a second laboratory and were correctly identified as positive or negative in at least one of two rounds of testing. Additionally, SARS-CoV-2 RNA was detected using this assay in the stool and anal swab specimens of 11 of 23 individuals known to be positive for SARS-CoV-2. Interpretation This is a sensitive and reproducible assay for detection of SARS-CoV-2 RNA in human stool, with potential uses in faecal microbiota transplantation donor screening, sewage monitoring, and further research into the effects of faecal shedding on the epidemiology of the COVID-19 pandemic. Copyright Published by Elsevier Ltd.
- Keyword:
- COVID-19
- Creator:
- Coryell, Michael P., Iakiviak, Mikhail, Pereira, Nicole, Murugkar, Pallavi P., Rippe, Jason, Williams, David B., Heald-Sargent, Taylor Alis, Sanchez-Pinto, L. Nelson, Chavez, Jairo, Hastie, Jessica L., Sava, Rosa L., Lien, Christopher Z., Wang, Tony T., Muller, William J., Fischbach, Michael A., Carlson, Paul E., Jr.
- Publisher:
- ELSEVIER
- Date Created:
- 2021-06
- Rights:
- http://creativecommons.org/licenses/by/4.0/
- Resource Type:
- Article
- Original Identifier:
- (PMID) 33821247
- Title:
- A Perspective on Emerging Therapeutic Interventions for COVID-19
- Description:
- Islam MT, Nasiruddin M, Khan IN, Mishra SK, Kudrat-E-Zahan M, Riaz TA, Ali ES, Rahman MS, Mubarak MS, Martorell M, Cho WC, Calina D, Docea AO, Sharifi-Rad J. A Perspective on Emerging Therapeutic Interventions for COVID-19. Frontiers in Public Health. 2020;8:15.
- Abstract:
- Coronaviruses are enveloped positive-sense RNA viruses with an unusual large RNA genome and a unique replication mechanism, which are characterized by club-like spikes that protrude from their surface. An outbreak of a novel coronavirus 2019 infection has posed significant threat to the health and economies in the whole world. This article reviewed the viral replication, pathogenicity, prevention and treatment strategies. With a lack of approved treatment options for this virus, alternative approaches to control the spread of disease is in urgent need. This article also covers some management strategies which may be applied to this virus outbreak. Ongoing clinical studies related to possible treatments for COVID-19, potential vaccines, and alternative medication such as natural compounds are also discussed.
- Keyword:
- SARS-CoV-2, COVID-19 pandemic, public health, control, therapeutics
- Creator:
- Torequl Islam, Muhammad, Nasiruddin, Md., Khan, Ishaq N., Mishra, Siddhartha Kumar, Kudrat-E-Zahan, Md., Alam Riaz, Thoufiqul, Ali, Eunus S., Rahman, M. Safiur, Mubarak, Mohammad S., Martorell, Miquel, Cho, William C., Calina, Daniela, Docea, Anca Oana, Sharifi-Rad, Javad
- Publisher:
- FRONTIERS MEDIA SA
- Date Created:
- 2020-07-03
- Rights:
- http://creativecommons.org/licenses/by/4.0/
- Resource Type:
- Review
- Original Identifier:
- (PMID) 32733837
- Title:
- A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy
- Description:
- Post LA, Argaw ST, Jones C, Moss CB, Resnick D, Singh LN, Murphy RL, Achenbach CJ, White J, Issa TZ, Boctor MJ, Oehmke JF. A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy. Journal of Medical Internet Research. 2020;22(11):18.
- Abstract:
- Background: Since the novel coronavirus emerged in late 2019, the scientific and public health community around the world have sought to better understand, surveil, treat, and prevent the disease, COVID-19. In sub-Saharan Africa (SSA), many countries responded aggressively and decisively with lockdown measures and border closures. Such actions may have helped prevent large outbreaks throughout much of the region, though there is substantial variation in caseloads and mortality between nations. Additionally, the health system infrastructure remains a concern throughout much of SSA, and the lockdown measures threaten to increase poverty and food insecurity for the subcontinent's poorest residents. The lack of sufficient testing, asymptomatic infections, and poor reporting practices in many countries limit our understanding of the virus's impact, creating a need for better and more accurate surveillance metrics that account for under-reporting and data contamination. Objective: The goal of this study is to improve infectious disease surveillance by complementing standardized metrics with new and decomposable surveillance metrics of COVID-19 that overcome data limitations and contamination inherent in public health surveillance systems. In addition to prevalence of observed daily and cumulative testing, testing positivity rates, morbidity, and mortality, we derived COVID-19 transmission in terms of speed, acceleration or deceleration, change in acceleration or deceleration (jerk), and 7-day transmission rate persistence, which explains where and how rapidly COVID-19 is transmitting and quantifies shifts in the rate of acceleration or deceleration to inform policies to mitigate and prevent COVID-19 and food insecurity in SSA. Methods: We extracted 60 days of COVID-19 data from public health registries and employed an empirical difference equation to measure daily case numbers in 47 sub-Saharan countries as a function of the prior number of cases, the level of testing, and weekly shift variables based on a dynamic panel model that was estimated using the generalized method of moments approach by implementing the Arellano-Bond estimator in R. Results: Kenya, Ghana, Nigeria, Ethiopia, and South Africa have the most observed cases of COVID-19, and the Seychelles, Eritrea, Mauritius, Comoros, and Burundi have the fewest. In contrast, the speed, acceleration, jerk, and 7-day persistence indicate rates of COVID-19 transmissions differ from observed cases. In September 2020, Cape Verde, Namibia, Eswatini, and South Africa had the highest speed of COVID-19 transmissions at 13.1, 7.1, 3.6, and 3 infections per 100,0000, respectively; Zimbabwe had an acceleration rate of transmission, while Zambia had the largest rate of deceleration this week compared to last week, referred to as ajerk. Finally, the 7-day persistence rate indicates the number of cases on September 15, 2020, which are a function of new infections from September 8, 2020, decreased in South Africa from 216.7 to 173.2 and Ethiopia from 136.7 to 106.3 per 100,000. The statistical approach was validated based on the regression results; they determined recent changes in the pattern of infection, and during the weeks of September 1-8 and September 9-15, there were substantial country differences in the evolution of the SSA pandemic. This change represents a decrease in the transmission model R value for that week and is consistent with a de-escalation in the pandemic for the sub-Saharan African continent in general. Conclusions: Standard surveillance metrics such as daily observed new COVID-19 cases or deaths are necessary but insufficient to mitigate and prevent COVID-19 transmission. Public health leaders also need to know where COVID-19 transmission rates are accelerating or decelerating, whether those rates increase or decrease over short time frames because the pandemic can quickly escalate, and how many cases today are a function of new infections 7 days ago. Even though SSA is home to some of the poorest countries in the world, development and population size are not necessarily predictive of COVID-19 transmission, meaning higher income countries like the United States can learn from African countries on how best to implement mitigation and prevention efforts.
- Keyword:
- global COVID-19 surveillance, African public health surveillance, sub-Saharan African COVID-19, African surveillance metrics, dynamic panel data, generalized method of the moments, African econometrics, African SARS-CoV-2, African COVID-19 surveillance system, African COVID-19 transmission speed, African COVID-19 transmission acceleration, COVID-19 transmission deceleration, COVID-19 transmission jerk, COVID-19 7-day persistence, Sao Tome and Principe, Senegal, Seychelles, Sierra Leone, Somalia, South Africa, South Sudan, Sudan, Suriname, Swaziland, Tanzania, Togo, Uganda, Zambia, Zimbabwe, Gambia, Ghana, Guinea, Guinea-Bissau, Kenya, Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Mauritius, Mozambique, Namibia, Niger, Nigeria, Rwanda, Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Central African Republic, Chad, Comoros, Congo, Cote d'Ivoire, Democratic Republic of Congo, Equatorial Guinea, Eritrea, Ethiopia, Gabon
- Creator:
- Post, Lori Ann, Argaw, Salem T., Jones, Cameron, Moss, Charles B., Resnick, Danielle, Singh, Lauren Nadya, Murphy, Robert Leo, Achenbach, Chad J., White, Janine Inui, Issa, Tariq Ziad, Boctor, Michael J., Oehmke, James Francis
- Publisher:
- JMIR PUBLICATIONS, INC
- Date Created:
- 2020-11-19
- Rights:
- http://creativecommons.org/licenses/by/4.0/
- Resource Type:
- Article
- Original Identifier:
- (PMID) 33211026
- Title:
- A Timely Call to Arms: COVID-19, the Circadian Clock, and Critical Care
- Description:
- Haspel J, Kim M, Zee P, Schwarzmeier T, Montagnese S, Panda S, Albani A, Merrow M. A Timely Call to Arms: COVID-19, the Circadian Clock, and Critical Care. Journal of Biological Rhythms. 2021;36(1):55-70.
- Abstract:
- We currently find ourselves in the midst of a global coronavirus disease 2019 (COVID-19) pandemic, caused by the highly infectious novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here, we discuss aspects of SARS-CoV-2 biology and pathology and how these might interact with the circadian clock of the host. We further focus on the severe manifestation of the illness, leading to hospitalization in an intensive care unit. The most common severe complications of COVID-19 relate to clock-regulated human physiology. We speculate on how the pandemic might be used to gain insights on the circadian clock but, more importantly, on how knowledge of the circadian clock might be used to mitigate the disease expression and the clinical course of COVID-19.
- Keyword:
- SARS-CoV-2, COVID-19, circadian clock, critical care, nutrition, zeitgeber, rhythm
- Creator:
- Haspel, Jeffrey, Kim, Minjee, Zee, Phyllis C, Schwarzmeier, Tanja, Montagnese, Sara, Panda, Satchidananda, Albani, Adriana, Merrow, Martha
- Publisher:
- SAGE PUBLICATIONS INC
- Date Created:
- 2021-02
- Rights:
- http://creativecommons.org/licenses/by/4.0/
- Resource Type:
- Review
- Original Identifier:
- (PMID) 33573430
- Title:
- Acral Changes in pediatric patients during COVID 19 pandemic: Registry report from the COVID 19 response task force of the society of pediatric dermatology (SPD) and pediatric dermatology research alliance (PeDRA)
- Description:
- Castelo-Soccio L, Lara-Corrales I, Paller AS, Bean E, Rangu S, Oboite M, Flohr C, Ahmad RC, Calberg V, Gilliam A, Pope E, Reynolds S, Sibbald C, Shin HT, Berger E, Schaffer J, Siegel MP, Cordoro KM. Acral Changes in pediatric patients during COVID 19 pandemic: Registry report from the COVID 19 response task force of the society of pediatric dermatology (SPD) and pediatric dermatology research alliance (PeDRA). Pediatric Dermatology. 2021;38(2):364-370.
- Abstract:
- Background/Objective In spring 2020, high numbers of children presented with acral pernio-like skin rashes, concurrent with the coronavirus disease 2019 (COVID-19) pandemic. Understanding their clinical characteristics/ infection status may provide prognostic information and facilitate decisions about management. Methods A pediatric-specific dermatology registry was created by the Pediatric Dermatology COVID-19 Response Task Force of the Society for Pediatric Dermatology (SPD) and Pediatric Dermatology Research Alliance (PeDRA) and was managed by Children's Hospital of Philadelphia using REDCap. Results Data from 378 children 0-18 years entered into the registry between April 13 and July 17, 2020 were analyzed. Data were drawn from a standardized questionnaire completed by clinicians which asked for demographics, description of acral lesions, symptoms before and after acral changes, COVID-19 positive contacts, treatment, duration of skin changes, laboratory testing including SARS-CoV-2 PCR and antibody testing, as well as histopathology. 229 (60.6%) were male with mean age of 13.0 years (+/- 3.6 years). Six (1.6%) tested positive for SARS-CoV-2. Pedal lesions (often with pruritus and/or pain) were present in 96%. 30% (114/378) had COVID-19 symptoms during the 30 days prior to presentation. Most (69%) had no other symptoms and an uneventful course with complete recovery. Conclusions and Relevance Children with acral pernio-like changes were healthy and all recovered with no short-term sequelae. We believe these acral changes are not just a temporal epiphenomenon of shelter in place during the spring months of the first wave of the COVID-19 pandemic and may be a late phase reaction that needs further study.
- Keyword:
- exanthems, infection-viral, skin signs of systemic disease
- Creator:
- Castelo-Soccio, Leslie, Lara-Corrales, Irene, Paller, Amy, Bean, Eric, Rangu, Sneha, Oboite, Michelle, Flohr, Carsten, Ahmad, Regina-Celeste, Calberg, Valerie, Gilliam, Amy, Pope, Elena, Reynolds, Sean, Sibbald, Cathryn, Shin, Helen T., Berger, Emily, Schaffer, Julie, Siegel, Michael P., Cordoro, Kelly M.
- Publisher:
- WILEY
- Date Created:
- 2021-03
- Rights:
- http://creativecommons.org/licenses/by-nc-nd/3.0/us/
- Resource Type:
- Article
- Original Identifier:
- (PMID) 33742457
- Title:
- Antibiotic-resistant bacteria: COVID-19 hasn't made the challenge go away
- Description:
- Waterer G, Pickens CI, Wunderink R. Antibiotic-resistant bacteria: COVID-19 hasn't made the challenge go away. Respirology. 2021;26(11):1024-1026.
- Keyword:
- antibiotics, antimicrobial stewardship, bacteria, pneumonia, resistance, life, care, end
- Creator:
- Waterer, Grant W, Pickens, Chiagozie Ifeoma, Wunderink, Richard G
- Publisher:
- WILEY
- Date Created:
- 2021-10-01
- Rights:
- http://creativecommons.org/licenses/by-nc-nd/3.0/us/
- Resource Type:
- Editorial
- Original Identifier:
- (PMID) 34596927
- Title:
- Anticoagulation practice patterns in COVID-19: A global survey
- Description:
- Rosovsky RP, Sanfilippo KM, Wang TF, Rajan SK, Shah S, Martin KA, Ainle FN, Huisman M, Hunt BJ, Kahn SR, Kevane B, Lee AYY, McLintock C, Kreuziger LB. Anticoagulation practice patterns in COVID-19: A global survey. Research and Practice in Thrombosis and Haemostasis. 2020;4(6):969-983.
- Abstract:
- Background Best practice for prevention, diagnosis, and management of venous thromboembolism (VTE) in patients with coronavirus disease 2019 (COVID-19) is unknown due to limited published data in this population. Objectives We aimed to assess current global practice and experience in management of COVID-19-associated coagulopathy to identify information to guide prospective and randomized studies. Methods Physicians were queried about their current approach to prophylaxis, diagnosis, and treatment of VTE in patients with COVID-19 using an online survey tool distributed through multiple international organizations between April 10 and 14, 2020. Results Five hundred fifteen physicians from 41 countries responded. The majority of respondents (78%) recommended prophylactic anticoagulation for all hospitalized patients with COVID-19, with most recommending use of low-molecular-weight heparin or unfractionated heparin. Significant practice variation was found regarding the need for dose escalation of anticoagulation outside the setting of confirmed or suspected VTE. Respondents reported the use of bedside testing when unable to perform standard diagnostic imaging for diagnosis of VTE. Two hundred ninety-one respondents reported observing thrombotic complications in their patients, with 64% noting that the complication was pulmonary embolism. Of the 44% of respondents who estimated incidence of thrombosis in patients with COVID-19 in their hospital, estimates ranged widely from 1% to 50%. One hundred seventy-four respondents noted bleeding complications (34% minor bleeding, 14% clinically relevant nonmajor bleeding, and 12% major bleeding). Conclusion Well-designed epidemiologic studies are urgently needed to understand the incidence and risk factors of VTE and bleeding complications in patients with COVID-19. Randomized clinical trials addressing use of anticoagulation are also needed.
- Keyword:
- anticoagulants, bleeding, blood coagulation, COVID-19, venous thromboembolism
- Creator:
- Rosovsky, Rachel P, Sanfilippo, Kristen M., Wang, Tzu Fei, Rajan, Sandeep K., Shah, Surbhi, Martin, Karlyn A, Ainle, Fionnuala Ni, Huisman, Menno, Hunt, Beverley J., Kahn, Susan R., Kevane, Barry, Lee, Agnes Y. Y., McLintock, Claire, Kreuziger, Lisa Baumann
- Publisher:
- WILEY
- Date Created:
- 2020-08
- Rights:
- http://creativecommons.org/licenses/by-nc-nd/3.0/us/
- Resource Type:
- Article
- Original Identifier:
- (PMID) 32838111
- Title:
- Attitudes and Perceptions of Telemedicine in Response to the COVID-19 Pandemic: A Survey of Nave Healthcare Providers
- Description:
- Schinasi DA, Foster CC, Bohling MK, Barrera L, Macy ML. Attitudes and Perceptions of Telemedicine in Response to the COVID-19 Pandemic: A Survey of Naive Healthcare Providers. Frontiers in Pediatrics. 2021;9:7.
- Abstract:
- Introduction: Expansion of telemedicine enabled healthcare access during the COVID-19 pandemic. In response to in-person visit restrictions, our institution trained >1,000 clinicians in telemedicine. Little is known about telemedicine-naive pediatric healthcare provider's perceptions as they adopted telemedicine practice. Methods: We conducted a cross-sectional survey of clinicians after expanding telemedicine practice at an independent children's hospital. The survey assessed experience with, concerns about, and intentions to continue telemedicine. Outpatient providers were included if they were first trained for telemedicine in response to COVID-19 and conducted at least one video visit, 3/21/2020-6/30/2020. Descriptive statistics were calculated; perceptions were compared across telemedicine activity level quartiles (based on proportions of visits delivered by video in June 2020) using Fisher's exact tests. Results: Of 609 survey responses, 305 (50.1%) met inclusion criteria, representing various roles and disciplines. Over half (54.1%) conducted >20 video visits 3/21/2020-6/30/2020. More than 75% of providers found telemedicine easy to learn. Providers with greater proportions of video visits in a typical week in June reported greater ease of incorporating telemedicine into clinical practice and greater intention to continue telemedicine practice in 6 months. Nearly all providers endorsed concerns. Patient care experiences reinforced technology-related concerns and alleviated liability and privacy concerns. Payer reimbursement was the leading influencer of anticipated future use of telemedicine. Discussion: Providers who conducted more telemedicine encounters reported greater ease of incorporating telemedicine into practice. Provider concerns were influenced by patient care experiences. Targeted training and quality improvement strategies are needed to sustain a robust post-pandemic telemedicine program.
- Keyword:
- telemedicine, telehealth, COVID-19, pediatric, children's hospital, healthcare provider
- Creator:
- Schinasi, Dana A., Foster, Carolyn C., Bohling, M. Katie, Barrera, Leonardo, Macy, Michelle L.
- Publisher:
- FRONTIERS MEDIA SA
- Date Created:
- 2021-04-07
- Rights:
- http://creativecommons.org/licenses/by/4.0/
- Resource Type:
- Article
- Original Identifier:
- (PMID) 33898361